Endo Bites – A Bite in Time: Wegovy Oral
In this episode, we cover:
· Where we currently stand with pharmacologic options for obesity treatment.
· What makes oral semaglutide fundamentally different from prior oral therapies.
· How oral semaglutide absorbed and how it works.
· What level of weight loss should clinicians realistically expect with oral Wegovy, particularly compared with other available obesity medications.
· Key prescribing considerations for clinicians, and the most important counseling points for patients.
· Cardiovascular considerations.
Host
Kate Glasenapp, DNP, APNP-BC, BC-ADM, CDCES, CBN, CSOWM
Assistant Professor, Division of Endocrinology & Molecular Medicine, Co-Director, MCW Medical Weight Loss and Bariatric Surgery Program, Froedtert & the Medical College of Wisconsin
Guest
Srividya Kidambi, MD, MS Professor of Medicine, Chief, Division of Endocrinology and Molecular Medicine, Co-Director of the Medical Weight Loss Program, Froedtert & the Medical College of Wisconsin
Disclaimer
The content of this podcast is for educational purposes only and is not intended as medical advice. Clinical decisions should be made based on individual patient circumstances and current clinical guidelines.